KemPharm
KMPH
#8927
Rank
NZ$0.36 B
Marketcap
NZ$10.58
Share price
-0.34%
Change (1 day)
9.90%
Change (1 year)

Earnings for KemPharm (KMPH)

Earnings in 2022 (TTM): -NZ$67.76 Million

According to KemPharm's latest financial reports the company's current earnings are NZ$10.45 Million. In 2021 the company made an earning of -NZ$14.83 Million a decrease over its 2020 earnings that were of -NZ$10.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for KemPharm from 2014 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$67.76 Million357.16%
2021 -NZ$14.83 Million39.34%
2020 -NZ$10.64 Million-67.62%
2019 -NZ$32.85 Million-63.58%
2018 -NZ$90.19 Million54.69%
2017 -NZ$58.3 Million224.53%
2016 -NZ$17.97 Million-79.67%
2015 -NZ$88.37 Million122.91%
2014 -NZ$39.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Theravance Biopharma
TBPH
NZ$0.10 B-240.61% Cayman Islands
Jazz Pharmaceuticals
JAZZ
NZ$0.47 B-719.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ANI Pharmaceuticals
ANIP
NZ$0.28 B-476.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-NZ$27.38 Million-64.14%๐Ÿ‡บ๐Ÿ‡ธ USA